Michal Schwartz

21PUBLICATIONS
48CO-AUTHORS
Medical infection agents (incl. prions)AutoimmunityInnate immunityEpigenetics (incl. genome methylation and epigenomics)Evolutionary ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 09, 2026
Bone marrow myelopoiesis dysfunction in Alzheimer's disease limits monocyte homing to the brain and drives disease progression.

|Jul 15, 2026
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

|Jun 19, 2026
Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.

|May 20, 2026
Treating the immune system to repair the brain.

|Apr 20, 2025
Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer's disease.

Javier María Peralta Ramos, Giulia Castellani, Denise Kviatcovsky

|Jan 06, 2025
Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer's disease.

Miguel A Abellanas, Maitreyee Purnapatre, Chiara Burgaletto

Pageof 4

Frequent Collaborators

9 joint publications

Tommaso Croese

6 joint publications

Javier Maria Peralta-Ramos

4 joint publications

Chiara Burgaletto

4 joint publications

Ido Amit